Atlas Trials

The Clinical Implications of Immune Checkpoint Pathways in PCNSL

Clinical trial NCT04158128 · COMPLETED

Trial details

NCT number
NCT04158128
Sponsor
National Taiwan University Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Lymphoma, B-Cell
Start date
2016-10-27
Primary completion
2022-12-31
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.